These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29531105)

  • 21. Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey.
    Lazarovich A; Chandrasekar T; Basnet A; Bratslavsky G; Goldberg H
    Can J Urol; 2023 Jun; 30(3):11551-11557. PubMed ID: 37344467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
    Chan EC; McFall SL; Byrd TL; Mullen PD; Volk RJ; Ureda J; Calderon-Mora J; Morales P; Valdes A; Kay Bartholomew L
    Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
    Han PK; Coates RJ; Uhler RJ; Breen N
    Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
    Molazem Z; Ebadi M; Khademian M; Zare R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.
    Kushalnagar P; Hill C; Carrizales S; Sadler GR
    J Cancer Educ; 2020 Feb; 35(1):28-35. PubMed ID: 30353474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
    Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
    J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.
    Li J; Berkowitz Z; Hall IJ
    J Am Board Fam Med; 2015; 28(4):491-3. PubMed ID: 26152440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
    Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
    J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
    Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
    Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Much Information Do Icelandic Men Receive on Pros and Cons of Prostate-Specific Antigen Testing Prior to Undergoing Testing?
    Eiriksdottir VK; Baldursdottir B; Fridriksson JO; Valdimarsdottir HB
    Am J Mens Health; 2022; 16(3):15579883221097805. PubMed ID: 35608380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of physician-patient discussions on the likelihood of prostate-specific antigen testing.
    Ross LE; Richardson LC; Berkowitz Z
    J Natl Med Assoc; 2006 Nov; 98(11):1823-9. PubMed ID: 17128693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
    Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
    Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.